Tumor Treating Fields in Neuro-Oncological Practice

Maciej Mrugala, Jacob Ruzevick, Piotr Zlomanczuk, Rimas V. Lukas

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Electric fields are known to produce biological effects. Depending on specific frequency, they can stimulate healing, directly damage tissues, or produce anti-mitotic activity. Frequencies of 100–300 KHz have been shown to disrupt mitosis and lead to cellular death. Growth of cancer cell lines, both in vitro and in vivo, was shown to be inhibited by application of the electric fields. In the clinical setting, electric fields are available for treatment of brain tumors, specifically glioblastoma (GBM), through a portable device producing so-called tumor treating fields (TTF). Clinical trials conducted in patients with recurrent and newly diagnosed GBM indicated that this novel treatment modality is active and associated with minimal toxicity. This manuscript will review the available evidence supporting the use of TTF in neuro-oncologic practice.

Original languageEnglish (US)
Article number53
JournalCurrent oncology reports
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Glioblastoma
Neoplasms
Mitosis
Brain Neoplasms
Clinical Trials
Cell Line
Equipment and Supplies
Therapeutics
Growth
In Vitro Techniques

Keywords

  • Bevacizumab
  • Glioblastoma
  • NovoTTF
  • Tumor treating fields

ASJC Scopus subject areas

  • Oncology

Cite this

Tumor Treating Fields in Neuro-Oncological Practice. / Mrugala, Maciej; Ruzevick, Jacob; Zlomanczuk, Piotr; Lukas, Rimas V.

In: Current oncology reports, Vol. 19, No. 8, 53, 01.08.2017.

Research output: Contribution to journalReview article

Mrugala, Maciej ; Ruzevick, Jacob ; Zlomanczuk, Piotr ; Lukas, Rimas V. / Tumor Treating Fields in Neuro-Oncological Practice. In: Current oncology reports. 2017 ; Vol. 19, No. 8.
@article{af4313488b014aefaa73753808cd6abd,
title = "Tumor Treating Fields in Neuro-Oncological Practice",
abstract = "Electric fields are known to produce biological effects. Depending on specific frequency, they can stimulate healing, directly damage tissues, or produce anti-mitotic activity. Frequencies of 100–300 KHz have been shown to disrupt mitosis and lead to cellular death. Growth of cancer cell lines, both in vitro and in vivo, was shown to be inhibited by application of the electric fields. In the clinical setting, electric fields are available for treatment of brain tumors, specifically glioblastoma (GBM), through a portable device producing so-called tumor treating fields (TTF). Clinical trials conducted in patients with recurrent and newly diagnosed GBM indicated that this novel treatment modality is active and associated with minimal toxicity. This manuscript will review the available evidence supporting the use of TTF in neuro-oncologic practice.",
keywords = "Bevacizumab, Glioblastoma, NovoTTF, Tumor treating fields",
author = "Maciej Mrugala and Jacob Ruzevick and Piotr Zlomanczuk and Lukas, {Rimas V.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s11912-017-0611-8",
language = "English (US)",
volume = "19",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "8",

}

TY - JOUR

T1 - Tumor Treating Fields in Neuro-Oncological Practice

AU - Mrugala, Maciej

AU - Ruzevick, Jacob

AU - Zlomanczuk, Piotr

AU - Lukas, Rimas V.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Electric fields are known to produce biological effects. Depending on specific frequency, they can stimulate healing, directly damage tissues, or produce anti-mitotic activity. Frequencies of 100–300 KHz have been shown to disrupt mitosis and lead to cellular death. Growth of cancer cell lines, both in vitro and in vivo, was shown to be inhibited by application of the electric fields. In the clinical setting, electric fields are available for treatment of brain tumors, specifically glioblastoma (GBM), through a portable device producing so-called tumor treating fields (TTF). Clinical trials conducted in patients with recurrent and newly diagnosed GBM indicated that this novel treatment modality is active and associated with minimal toxicity. This manuscript will review the available evidence supporting the use of TTF in neuro-oncologic practice.

AB - Electric fields are known to produce biological effects. Depending on specific frequency, they can stimulate healing, directly damage tissues, or produce anti-mitotic activity. Frequencies of 100–300 KHz have been shown to disrupt mitosis and lead to cellular death. Growth of cancer cell lines, both in vitro and in vivo, was shown to be inhibited by application of the electric fields. In the clinical setting, electric fields are available for treatment of brain tumors, specifically glioblastoma (GBM), through a portable device producing so-called tumor treating fields (TTF). Clinical trials conducted in patients with recurrent and newly diagnosed GBM indicated that this novel treatment modality is active and associated with minimal toxicity. This manuscript will review the available evidence supporting the use of TTF in neuro-oncologic practice.

KW - Bevacizumab

KW - Glioblastoma

KW - NovoTTF

KW - Tumor treating fields

UR - http://www.scopus.com/inward/record.url?scp=85021655163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021655163&partnerID=8YFLogxK

U2 - 10.1007/s11912-017-0611-8

DO - 10.1007/s11912-017-0611-8

M3 - Review article

C2 - 28664468

AN - SCOPUS:85021655163

VL - 19

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 8

M1 - 53

ER -